Standard

PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER. / Kolbin, A.; Vilum, I.; Balykina, Y.; Proskurin, M.

в: Value in Health, Том 22, 11.2019, стр. S510-S510.

Результаты исследований: Научные публикации в периодических изданиях › тезисы › Рецензирование

Harvard

Kolbin, A, Vilum, I, Balykina, Y & Proskurin, M 2019, 'PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER', Value in Health, Том. 22, стр. S510-S510.

APA

Kolbin, A., Vilum, I., Balykina, Y., & Proskurin, M. (2019). PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER. Value in Health, 22, S510-S510.

Vancouver

Kolbin A, Vilum I, Balykina Y, Proskurin M. PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER. Value in Health. 2019 Нояб.;22:S510-S510.

Author

Kolbin, A. ; Vilum, I. ; Balykina, Y. ; Proskurin, M. / PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER. в: Value in Health. 2019 ; Том 22. стр. S510-S510.

BibTeX

@article{dc143fb761e24f10bf3086a1ca15e520,
title = "PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER",
author = "A. Kolbin and I. Vilum and Y. Balykina and M. Proskurin",
year = "2019",
month = nov,
language = "Английский",
volume = "22",
pages = "S510--S510",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - PHARMACOECONOMIC ANALYSIS OF ATEZOLIZUMAB PLUS NAB-PACLITAXEL IN THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

AU - Kolbin, A.

AU - Vilum, I.

AU - Balykina, Y.

AU - Proskurin, M.

PY - 2019/11

Y1 - 2019/11

M3 - тезисы

VL - 22

SP - S510-S510

JO - Value in Health

JF - Value in Health

SN - 1098-3015

ER -

ID: 50366005